Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for ...
First and only therapy FDA approved in both R/R acute myeloid leukemia (AML) with an NPM1 mutation and R/R acute leukemia with a KMT2A translocation – – Second approved indication for Revuforj in less ...
A bill passed this week by the Ohio House would establish licensed hemp dispensaries, safety testing requirements, and ...
Pharmaceutical Technology on MSN
Lilly and Incyte to seek approval of alopecia JAK inhibitor in children
Lilly and Inctye will be seeking a label update for the JAK inhibitor for its use in paediatric patients with alopecia areata ...
Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found ...
More Americans now use marijuana than smoke cigarettes amid shifting perceptions of harm of the two substances, according to ...
Achieves significant expansion of NeurAxis’ total addressable marketClearance now includes patients aged '8 years and older”Expanded age indication will utilize the upcoming January 1st, 2026, ...
Guselkumab offers the flexibility of self-administration from the start of treatment in both ulcerative colitis (UC) and Crohn’s disease (CD),1,2,3 providing the simplicity of a fully subcutaneous ...
If you or someone you know is in immediate danger as a result of domestic violence, call 911. For anonymous, confidential ...
Suspected grooming gangs cases exposed by Standard investigation to be reexamined as part of huge Met Police review ...
For the last weeks of her life, Natalie, now 44, watched her daughter writhing in agony as her bladder was stripped of its ...
If you or someone you know is in immediate danger as a result of domestic violence, call 911. For anonymous, confidential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback